site-robux[.]replit[.]app
“Roblox Robux Page”
Resumen de las pruebas
Analysis indicates that the domain site-robux.replit.app was registered through Replit Inc. and currently resolves to the IPv4 address 34.117.33.233, which is part of the Amazon Web Services hosting range. The domain is listed on a single security blocklist, PhishDestroy, which has actively blocked traffic to the host. No authoritative nameserver records were returned (NS_NOT_FOUND), suggesting either a misconfiguration or intentional obfuscation of DNS infrastructure. The threat classification is generic phishing, and the domain remains active as of the report date, August 07, 2026, with its risk level marked as under investigation.
Publicly available metadata does not include a page title, SSL certificate details, HTTP response codes, or Safe Browsing verdicts, so the content and transport security posture cannot be confirmed at this time. The absence of these signals limits the ability to attribute a specific credential‑stealing kit or to confirm whether the site serves malicious payloads. However, the presence on PhishDestroy and the use of a reputable cloud provider for hosting are consistent with observed patterns of phishing operators who leverage inexpensive cloud instances to reduce attribution risk. Defenders should prioritize adding the domain and its resolving IP address to local blocklists and network‑level deny lists.
Monitoring DNS queries for the domain and for the IP range 34.112.0.0/12 (AWS) can help detect opportunistic reuse. Because the nameserver information is missing, investigators may query passive DNS services for historical NS records that could reveal additional infrastructure. Continuous re‑evaluation is advised; if future scans surface malicious payloads or if the domain appears on additional blocklists, the risk rating should be escalated accordingly.
Data Coverage
Proceso de respuesta ante amenazas Pipeline
Cobertura de listas de bloqueo
10 fuentes externas supervisadas · instantánea del 11/08/2026
10 fuentes externas supervisadas Sin coincidencias
Cronología de detección
-
Primer registro
Primer valor almacenado: Accesible
Captura guardada
Inteligencia de dominios
Detalles técnicosDNS, nombres TLS y marcas de tiempo
ICANN OVERSIGHT
Registration: replit.app
Acreditación y contexto RAA
Acreditación y contexto RAA
Registrar accreditation and DNS abuse obligations
For the registrable domain replit.app behind this subdomain, the registrar above operates under an ICANN accreditation agreement. The links below provide the official fee schedule and current DNS abuse compliance guidance.
Accreditation is a contract, not a safety certification.
RAA §3.18 establishes abuse-contact and handling requirements. This report can document stored outbound notices and later technical observations; it does not by itself establish receipt, investigation, remediation, or contractual non-compliance.
Tecnologías
7 tecnologías identificadas con alta confianza
Análisis de VirusTotal
Evidencias archivadas
Análisis del rendimiento del sitio
Google PageSpeed Insights — mobile performance audit of site-robux.replit.app · checked Aug 7, 2026
Análisis de la configuración del sitio
¿Te ha afectado esta página web?
Si ingresó credenciales de cuenta, información personal o de pago, o descargó un archivo de este dominio, tome medidas inmediatas. A continuación encontrará recursos que le ayudarán a informar el incidente y protegerse.
Informa a las autoridades locales
Seleccione su país para obtener contactos oficiales de cibercrimen o crear un borrador de queja →.
Comprobar cualquier dominio
Análisis de amenazas utilizando listas de bloqueo almacenadas, WHOIS, DNS y evidencia de escaneo público
Escanear ahoraDenunciar un intento de phishing
Envía los dominios sospechosos a nuestra base de datos de amenazas: protege a la comunidad
DenunciarFlujo de amenazas en tiempo real
Informes de phishing recientes y cambios de disponibilidad observados
MonitorizarMantente informado, mantente a salvo
Supervisa las amenazas en tiempo real o impugna esta entrada si crees que se trata de un falso positivo.